Adynxx, Inc.   Report issue

For profit Phase 2
Founded: San Francisco CA United States (2007)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2013
NCT01731730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Adynxx, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

Key: Adynxx, Inc. (1) Acquired (1)

ayx1 (5 trials)

cannabis (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 2